Northland initiated coverage of Connect Biopharma (CNTB) with an Outperform rating and $7.50 price target
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNTB:
- Connect Biopharma Ends ADS Agreement with Deutsche Bank
- Connect Biopharma plans to terminate ADR program, list shares on Nasdaq
- Connect Biopharma Regains Nasdaq Compliance
- Connect Biopharma regains Nasdaq compliance
- Connect Biopharma Holdings: A Promising Investment with Strategic Drug Developments and Strong Financial Position